News
Avastin vindicated as AMD treatment
Many ophthalmologists have opted to use Avastin to treat their patients for wet age-related macular degeneration. Lucentis is the approved drug for treatment but is cost prohibitive for many patien...
FDA approves eye telescope for blind AMD patients
Those who suffer from end-stage age-related macular degeneration (AMD) will now have access to an implantable optical device that restores vision. The FDA recently approved the implantable device. ...
Gene linked to common form of Fuchs corneal dystrophy discovered
Researchers have discovered a gene that is linked to the most common form of Fuchs corneal dystrophy (FCD). The study was published in the New England Journal of Medicine online.? Previously, resea...
Lack of Eye pigment associated with AMD risk
Age-related macular degeneration is the leading cause of blindness in Ireland. Researchers with a team at the Waterford Institute of Technology have discovered that an increase in body weight may r...
Does cataract surgery increase the chances of retinal problems?
[caption id="attachment_1544" align="alignright" width="200"]
New Hope for Acid burns to the eye...
Every year, thousands of people suffer chemical burns to their eyes resulting in blindness.? A recent study of patients who received adult stem cell transplants found that the patients had their vi...
Gene linked to myopia discovered
Researchers have identified a gene linked to myopia in Caucasian people from varying regions of the world. Several unique spellings of DNA code near the RASGRF1 gene had a strong link with focusing...
Elsie Gerner update on her macular degeneration
(The following email came from Elsie Gerner, who has been taking VisiVite since 2001.)
[caption id="attachment_1518" align="alignright" width="300"]
C-Reactive protein increases risk of AMD
[caption id="attachment_1508" align="alignright" width="223"]